mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.084 |
0.09 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.089 |
0.09 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |